1 / 1

Understanding IgVH Status in CLL Patients: Risk Stratification and Clinical Implications

Explore the significance of IgVH mutational status in chronic lymphocytic leukemia (CLL) patients for risk stratification and treatment decisions. Learn about the impact of low, intermediate, and high-risk categories on disease progression and outcomes.

noelle
Download Presentation

Understanding IgVH Status in CLL Patients: Risk Stratification and Clinical Implications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. IgVH unmutated IgVH mutated Low-risk Intermediate-risk High-risk P14 cluster N6 cluster ZAP-70 CD38 IgVH status Supplementary Figure 1

More Related